PURPOSE: The utility of the apparent diffusion coefficient (ADC) in patients with clear-cell renal cell carcinoma (RCC) for distinguishing between the four clinical stages was assessed.
METHODS: Forty-nine patients with pathologically proven RCCs (I, II, III, IV; 27, 5, 10, 7) were included. The ADC was compared between each stage.
RESULTS: The difference of ADC between stage I and the more advanced stages (III and IV) was statistically significant.
CONCLUSIONS: When ADC in primary tumor site of clear-cell RCC would be higher than the cutoff level, the stage might not be an advanced stage (III or IV).
Written by:
Nakamura T, Yoshizako T, Araki H, Maruyama M, Uchida K, Tamaki Y, Ishikawa N, Shiina H, Kitagaki H. Are you the author?
Department of Radiology, Shimane University Faculty of Medicine, P.O. Box 00693-8501, 89-1 Enya, Izumo, Japan; Department of Organ Pathology, Shimane University Faculty of Medicine, P.O. Box 00693-8501, 89-1 Enya, Izumo, Japan; Department of Urology, Shimane University Faculty of Medicine, P.O. Box 00693-8501, 89-1 Enya, Izumo, Japan.
Reference: Clin Imaging. 2015 Jan-Feb;39(1):72-5.
doi: 10.1016/j.clinimag.2014.09.006
PubMed Abstract
PMID: 25457531